Life AI Net
Home
Archive
Calculators
Directory
Newsletter
Login
English
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Home
Archive
Calculators
Directory
Newsletter
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Login
Home
Archive
Calculators
Directory
More
Live
Endpoints News
Industry seeks more clarity on commissioner's voucher program
BioWorld
Money raised by biopharma
BioWorld
Biopharma money raised: Jan. 1-June 4, 2026
BioWorld
BioWorld and Nasdaq stock indices
Endpoints News
House committee directs FDA to speed up IND sign-off process
FierceBiotech
Executive Interviews at Fierce Biotech Week 2026
BioWorld
Biopharma money raised by month in 2026 (US$M)
BioPharma Dive
Study data convince Lundbeck to push new migraine drug forward
BioPharma Dive
Generic drugmakers gain key victory in ‘skinny label’ patent case
Endpoints News
Innovent declares Phase 3 success for ADC that attracted huge Takeda deal
FierceBiotech
Affibody gets izokibep ‘back on track’ while seeking ‘new home’ after drug’s Acelyrin rejection
Clinical OMICs
Influenza Drugs Could Prevent Cognitive Decline in Chronic Viral Infections
Endpoints News
Industry seeks more clarity on commissioner's voucher program
BioWorld
Money raised by biopharma
BioWorld
Biopharma money raised: Jan. 1-June 4, 2026
BioWorld
BioWorld and Nasdaq stock indices
Endpoints News
House committee directs FDA to speed up IND sign-off process
FierceBiotech
Executive Interviews at Fierce Biotech Week 2026
BioWorld
Biopharma money raised by month in 2026 (US$M)
BioPharma Dive
Study data convince Lundbeck to push new migraine drug forward
BioPharma Dive
Generic drugmakers gain key victory in ‘skinny label’ patent case
Endpoints News
Innovent declares Phase 3 success for ADC that attracted huge Takeda deal
FierceBiotech
Affibody gets izokibep ‘back on track’ while seeking ‘new home’ after drug’s Acelyrin rejection
Clinical OMICs
Influenza Drugs Could Prevent Cognitive Decline in Chronic Viral Infections
Archive
This story is not available in the archive.